RGEBX
Price
$83.14
Change
+$0.13 (+0.16%)
Updated
Sep 18 closing price
Net Assets
353.07B
TBDCX
Price
$13.45
Change
+$0.06 (+0.45%)
Updated
Sep 18 closing price
Net Assets
436.55M
Interact to see
Advertisement

RGEBX vs TBDCX

RGEBX vs TBDCX Comparison Chart in %
View a ticker or compare two or three
VS
RGEBX vs. TBDCX commentary
Sep 21, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGEBX is a Hold and TBDCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 353B vs. TBDCX (437M). RGEBX (0.00) and TBDCX (0.00) have matching dividends . RGEBX was incepted earlier than TBDCX: RGEBX (12 years) vs TBDCX (27 years). TBDCX (1.87) is less costly to investors than RGEBX (1.08). TBDCX is a more actively managed with annual turnover of: 122.00 vs. RGEBX (32.00). RGEBX has a lower initial minimum investment than TBDCX: RGEBX (250) vs TBDCX (1000). TBDCX annual gain was more profitable for investors over the last year : 0.00 vs. RGEBX (-1.95). RGEBX return over 5 years is better than : 9.39 vs. TBDCX (-10.51).
RGEBXTBDCXRGEBX / TBDCX
Total Expense Ratio1.081.8160%
Annual Report Gross Expense Ratio1.081.8758%
Fund Existence12 years27 years-
Gain YTD8.4536.073139%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets353B437M80,778%
Annual Yield % from dividends0.000.00-
Returns for 1 year-1.950.00-
Returns for 3 years41.1735.72115%
Returns for 5 years9.39-10.51-89%
Returns for 10 years95.5142.78223%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DESIX13.700.07
+0.51%
DFA Em Mkts Sustnby Cor 1 Instl
FBAQX35.26-0.01
-0.03%
Fidelity Advisor® Balanced M
NWXQX17.24-0.05
-0.29%
Nationwide Mid Cap Market Idx Instl Svc
FRVLX65.38-0.26
-0.40%
Franklin Small Cap Value A
CRRVX10.18-0.08
-0.78%
Columbia Real Estate Equity Inst2